Video index

1. Call to order (Part 1 of 2)

2. Consideration of October 12, 2023, and October 13, 2023, draft meeting minutes (Part 1 of 2)

3. HHS Ethics Policy overview

4. 88th Texas Legislature, Regular Session (2023), House Bill 3286 Update

1. Call to order (Part 2 of 2)

2. Consideration of October 12, 2023, and October 13, 2023, draft meeting minutes (Part 2 of 2)

5. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

6. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL

7. Therapeutic and clinical drug reviews, updates, and discussion: Magellan Medicaid Administration

8. Executive work session

9. Announcements of drugs recommended for the Medicaid PDL: Magellan Medicaid Administration

10. Prospective prior authorization proposals (clinical edits): Kepro, LLC

11. Retrospective drug use criteria for outpatient use in Vendor Drug Program: The University of Texas at Austin College of Pharmacy

12. Review of action items for next meeting: April 26, 2024, 9:00 a.m.

Jan 26, 2024 Drug Utilization Review Board (DURB) Agenda

Full agenda
Share this video

1. Call to order (Part 1 of 2)

2. Consideration of October 12, 2023, and October 13, 2023, draft meeting minutes (Part 1 of 2)

3. HHS Ethics Policy overview

4. 88th Texas Legislature, Regular Session (2023), House Bill 3286 Update

1. Call to order (Part 2 of 2)

2. Consideration of October 12, 2023, and October 13, 2023, draft meeting minutes (Part 2 of 2)

5. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

6. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL

7. Therapeutic and clinical drug reviews, updates, and discussion: Magellan Medicaid Administration

8. Executive work session

9. Announcements of drugs recommended for the Medicaid PDL: Magellan Medicaid Administration

10. Prospective prior authorization proposals (clinical edits): Kepro, LLC

11. Retrospective drug use criteria for outpatient use in Vendor Drug Program: The University of Texas at Austin College of Pharmacy

12. Review of action items for next meeting: April 26, 2024, 9:00 a.m.

© 2003-2024 Swagit Productions, LLC